tiprankstipranks
Health Sciences Acquisitions 2 (HSAQ)
NASDAQ:HSAQ
US Market

Health Sciences Acquisitions 2 (HSAQ) Stock News & Sentiment

0 Followers
Orchestra BioMed begins trading on Nasdaq with cash runway into 2026
PremiumThe Fly
Orchestra BioMed begins trading on Nasdaq with cash runway into 2026
1y ago
Orchestra BioMed (OBIO) closed its business combination with Health Sciences Acquisitions 2 (HSAQ). Common stock of the combined company called "Orchestra BioMed Holdings, Inc.", commenced trading on January 27 on ...Read more
Health Sciences Acquisitions CEO buys $18.1M in common stock
PremiumThe Fly
Health Sciences Acquisitions CEO buys $18.1M in common stock
1y ago

News Score - Last 7 Days

Neutral
HSAQ
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HSAQ’s Media Buzz Sentiment?
2 articles about HSAQ were published this week. In an average week, 1 articles are published.
    What is HSAQ’s weekly average amount of articles?
    In an average week, 1 articles about HSAQ are published.
      What is HSAQ’s News Sentiment?
      50% of articles about HSAQ were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        FDMT4D Molecular Therapeutics
        SYKStryker
        TSHATaysha Gene Therapies
        CEMIChembio Diagnostics
        ZIMVZimVie Inc
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis